PL234888B1 - Dendrymer polipropylenoiminowy czwartej generacji opłaszczony maltotriozą PPI-G4-OS-Mal-III do zastosowania w leczeniu przewlekłej białaczki limfocytowej - Google Patents
Dendrymer polipropylenoiminowy czwartej generacji opłaszczony maltotriozą PPI-G4-OS-Mal-III do zastosowania w leczeniu przewlekłej białaczki limfocytowej Download PDFInfo
- Publication number
- PL234888B1 PL234888B1 PL401936A PL40193612A PL234888B1 PL 234888 B1 PL234888 B1 PL 234888B1 PL 401936 A PL401936 A PL 401936A PL 40193612 A PL40193612 A PL 40193612A PL 234888 B1 PL234888 B1 PL 234888B1
- Authority
- PL
- Poland
- Prior art keywords
- ppi
- mal
- iii
- cells
- dendrimer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
- C08G83/002—Dendritic macromolecules
- C08G83/003—Dendrimers
- C08G83/004—After treatment of dendrimers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL401936A PL234888B1 (pl) | 2012-12-06 | 2012-12-06 | Dendrymer polipropylenoiminowy czwartej generacji opłaszczony maltotriozą PPI-G4-OS-Mal-III do zastosowania w leczeniu przewlekłej białaczki limfocytowej |
| CA2893973A CA2893973A1 (en) | 2012-12-06 | 2013-12-06 | Application of maltotriose-coated 4th generation polypropyleneimine dendrimer ppi-g4-os-mal-iii |
| KR1020157018094A KR20150093216A (ko) | 2012-12-06 | 2013-12-06 | 말토트리오즈-코팅된 제 4 세대 폴리프로필렌이민 덴르리머 PPI-G4-OS-Mal-III의 적용 |
| AU2013356793A AU2013356793A1 (en) | 2012-12-06 | 2013-12-06 | Application of maltotriose-coated 4th generation polypropyleneimine dendrimer PPI-G4-OS-Mal-III |
| JP2015546419A JP2016501261A (ja) | 2012-12-06 | 2013-12-06 | マルトトリオースで被覆された第四世代ポリプロピレンイミンデンドリマーPPI−G4−OS−Mal−IIIの使用 |
| PCT/PL2013/000163 WO2014088435A1 (en) | 2012-12-06 | 2013-12-06 | Application of maltotriose-coated 4th generation polypropyleneimine dendrimer ppi-g4-os-mal-iii |
| US14/650,521 US9877985B2 (en) | 2012-12-06 | 2013-12-06 | Application of maltotriose-coated 4th generation polypropyleneimine dendrimer PPI-G4-OS-MAL-III |
| EP13821004.2A EP2928479A1 (en) | 2012-12-06 | 2013-12-06 | Application of maltotriose-coated 4th generation polypropyleneimine dendrimer ppi-g4-os-mal-iii |
| IL239144A IL239144A0 (en) | 2012-12-06 | 2015-06-02 | Application of a fourth-generation polypropyleneamine dendrimer ppi–g4–os–mal–iii coated with maltotriose |
| US15/846,143 US10022395B2 (en) | 2012-12-06 | 2017-12-18 | Application of maltotriose-coated 4th generation poly(propyleneimine) dendrimer PPI-G4-OS-Mal-III |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL401936A PL234888B1 (pl) | 2012-12-06 | 2012-12-06 | Dendrymer polipropylenoiminowy czwartej generacji opłaszczony maltotriozą PPI-G4-OS-Mal-III do zastosowania w leczeniu przewlekłej białaczki limfocytowej |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL401936A1 PL401936A1 (pl) | 2014-06-09 |
| PL234888B1 true PL234888B1 (pl) | 2020-04-30 |
Family
ID=49955472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL401936A PL234888B1 (pl) | 2012-12-06 | 2012-12-06 | Dendrymer polipropylenoiminowy czwartej generacji opłaszczony maltotriozą PPI-G4-OS-Mal-III do zastosowania w leczeniu przewlekłej białaczki limfocytowej |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9877985B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2928479A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2016501261A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20150093216A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2013356793A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2893973A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL239144A0 (cg-RX-API-DMAC10.html) |
| PL (1) | PL234888B1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2014088435A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL234887B1 (pl) * | 2012-12-06 | 2020-04-30 | Univ Lodzki | Dendrymer polipropylenoiminowy czwartej generacji opłaszczony maltotriozą PPI-G4-DS-Mal-III do zastosowania w leczeniu przewlekłej białaczki limfocytowej |
| PL416636A1 (pl) * | 2016-03-24 | 2017-09-25 | Univ Łódzki | Medyczne zastosowanie dendrymeru polipropylenoiminowego czwartej generacji, opłaszczonego maltotriozą |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090208580A1 (en) | 2005-09-19 | 2009-08-20 | Regents Of The University Of Michigan | Functionalized dendrimer-encapsulated and dendrimer-stabilized nanoparticles |
| US20110177602A1 (en) * | 2007-06-27 | 2011-07-21 | Endress + Hauser Conducts Gesellschaft furMess-und Regeltechnik mbH +Co. KG | Composite Structure |
| PL234887B1 (pl) * | 2012-12-06 | 2020-04-30 | Univ Lodzki | Dendrymer polipropylenoiminowy czwartej generacji opłaszczony maltotriozą PPI-G4-DS-Mal-III do zastosowania w leczeniu przewlekłej białaczki limfocytowej |
-
2012
- 2012-12-06 PL PL401936A patent/PL234888B1/pl unknown
-
2013
- 2013-12-06 CA CA2893973A patent/CA2893973A1/en not_active Abandoned
- 2013-12-06 EP EP13821004.2A patent/EP2928479A1/en not_active Withdrawn
- 2013-12-06 KR KR1020157018094A patent/KR20150093216A/ko not_active Withdrawn
- 2013-12-06 US US14/650,521 patent/US9877985B2/en not_active Expired - Fee Related
- 2013-12-06 JP JP2015546419A patent/JP2016501261A/ja active Pending
- 2013-12-06 AU AU2013356793A patent/AU2013356793A1/en not_active Abandoned
- 2013-12-06 WO PCT/PL2013/000163 patent/WO2014088435A1/en not_active Ceased
-
2015
- 2015-06-02 IL IL239144A patent/IL239144A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20150093216A (ko) | 2015-08-17 |
| AU2013356793A1 (en) | 2015-07-23 |
| CA2893973A1 (en) | 2014-06-12 |
| WO2014088435A1 (en) | 2014-06-12 |
| PL401936A1 (pl) | 2014-06-09 |
| US20150306134A1 (en) | 2015-10-29 |
| EP2928479A1 (en) | 2015-10-14 |
| US9877985B2 (en) | 2018-01-30 |
| JP2016501261A (ja) | 2016-01-18 |
| IL239144A0 (en) | 2015-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sun et al. | Light-activated gold–selenium core–shell nanocomposites with NIR-II photoacoustic imaging performances for heart-targeted repair | |
| Zhang et al. | Co-delivery of etoposide and cisplatin in dual-drug loaded nanoparticles synergistically improves chemoradiotherapy in non-small cell lung cancer models | |
| US20220347314A1 (en) | Microbubble-chemotherapeutic agent complex for sonodynamic therapy | |
| Tian et al. | Improving DNA double-strand repair inhibitor KU55933 therapeutic index in cancer radiotherapy using nanoparticle drug delivery | |
| Cosco et al. | In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer | |
| Gorzkiewicz et al. | Dendrimers as nanocarriers for nucleoside analogues | |
| CN105287383A (zh) | 新型米托蒽醌脂质体联合化疗药物在抗肿瘤治疗中的应用 | |
| JP2021512110A (ja) | ペンタアザ大環状環複合体および白金を基にした抗癌剤による組み合わせ癌療法 | |
| Zhang et al. | Hypoxia-triggered tumor specific glutamine inhibition for reversing cisplatin resistance of chemotherapy | |
| US10925852B2 (en) | Talc-bound compositions and uses thereof | |
| KR19990036137A (ko) | 암 성장을 억제하기 위한 그리세오풀빈의 용도 | |
| WO2019073296A1 (en) | LIPOSOMAL FORMULATIONS OF BISANTRENE OR DERIVATIVES OR THE LIKE THEREOF | |
| EP2825198B1 (en) | Glut-1 targeted and curcumin loaded micelles | |
| PL234887B1 (pl) | Dendrymer polipropylenoiminowy czwartej generacji opłaszczony maltotriozą PPI-G4-DS-Mal-III do zastosowania w leczeniu przewlekłej białaczki limfocytowej | |
| US9877985B2 (en) | Application of maltotriose-coated 4th generation polypropyleneimine dendrimer PPI-G4-OS-MAL-III | |
| JP7454263B2 (ja) | 高分子薬剤 | |
| Dohadwala et al. | Novel Oncologic Strategies in Osteosarcoma Management: Maximizing Impact, Minimizing Harm | |
| CN1046464A (zh) | 减少药物副效应的方法 | |
| WO2017163124A2 (en) | Medical use of poly(propylene imine) glycodendrimers | |
| PL238795B1 (pl) | Ekstrakt z grzyba poliporoidalnego, kompozycja zawierająca taki ekstrakt oraz jego zastosowanie | |
| PL241754B1 (pl) | Sposób wytwarzania układu zawierającego nanocząstki złota oraz wytworzony tym sposobem układ zawierający nanocząstki złota do zastosowania w terapii przeciwnowotworowej | |
| EP4450092A1 (en) | Modified oligonucleotide-drug conjugate and use thereof | |
| RU2372073C1 (ru) | Доставка гетероциклических антибиотиков к раковым клеткам с помощью нанонуклеотидных фармакосом | |
| Tannous | The combination of Gadolinium-based nanoparticles, radiotherapy and immune checkpoint inhibitors: a novel therapeutic opportunity for cancer treatment | |
| Jayawardhana | Development of Photoactivatable Platinum Therapeutics to Eradicate Ovarian Cancer Stem Cells |